Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Primary mammary small-cell carcinoma: a molecular analysis of 2 cases.

Hoang MP, Maitra A, Gazdar AF, Albores-Saavedra J.

Hum Pathol. 2001 Jul;32(7):753-7.

PMID:
11486176
2.

Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast.

Palacios J, Sarrió D, García-Macias MC, Bryant B, Sobel ME, Merino MJ.

Mod Pathol. 2003 Jul;16(7):674-8.

3.

Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.

Shin SJ, Simpson PT, Da Silva L, Jayanthan J, Reid L, Lakhani SR, Rosen PP.

Am J Surg Pathol. 2009 Apr;33(4):496-504. doi: 10.1097/PAS.0b013e31818af361.

PMID:
19047897
4.
5.

Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: correlation with proliferative activity, ploidy and hormonal status of the tumors.

Kouvaraki M, Gorgoulis VG, Rassidakis GZ, Liodis P, Koutroumbi E, Markopoulos C, Gogas J, Kittas C.

Anticancer Res. 2001 Mar-Apr;21(2A):991-9.

PMID:
11396193
6.

Invasive tubular carcinoma of the breast frequently is clonally related to flat epithelial atypia and low-grade ductal carcinoma in situ.

Aulmann S, Elsawaf Z, Penzel R, Schirmacher P, Sinn HP.

Am J Surg Pathol. 2009 Nov;33(11):1646-53. doi: 10.1097/PAS.0b013e3181adfdcf.

PMID:
19675453
7.

Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas.

Simpson PT, Reis-Filho JS, Lambros MB, Jones C, Steele D, Mackay A, Iravani M, Fenwick K, Dexter T, Jones A, Reid L, Da Silva L, Shin SJ, Hardisson D, Ashworth A, Schmitt FC, Palacios J, Lakhani SR.

J Pathol. 2008 Jul;215(3):231-44. doi: 10.1002/path.2358.

PMID:
18473330
8.

Molecular and biomarker analyses of salivary duct carcinomas: comparison with mammary duct carcinoma.

Hoang MP, Callender DL, Sola Gallego JJ, Huang Z, Sneige N, Luna MA, Batsakis JG, El-Naggar AK.

Int J Oncol. 2001 Oct;19(4):865-71.

PMID:
11562768
9.

Small cell carcinoma of the gallbladder: a clinicopathologic, immunohistochemical, and molecular pathology study of 12 cases.

Maitra A, Tascilar M, Hruban RH, Offerhaus GJ, Albores-Saavedra J.

Am J Surg Pathol. 2001 May;25(5):595-601.

PMID:
11342770
10.

Characteristics of loss of heterozygosity in large cell neuroendocrine carcinomas of the lung and small cell lung carcinomas.

Takeuchi T, Minami Y, Iijima T, Kameya T, Asamura H, Noguchi M.

Pathol Int. 2006 Aug;56(8):434-9.

PMID:
16872437
11.
12.

Breast carcinoma diverging to aberrant melanocytic differentiation: a case report with histopathologic and loss of heterozygosity analyses.

Nobukawa B, Fujii H, Hirai S, Kumasaka T, Shimizu H, Matsumoto T, Suda K, Futagawa S.

Am J Surg Pathol. 1999 Oct;23(10):1280-7.

PMID:
10524531
13.

Clonality analysis of different histological components in combined small cell and non-small cell carcinoma of the lung.

Murase T, Takino H, Shimizu S, Inagaki H, Tateyama H, Takahashi E, Matsuda H, Eimoto T.

Hum Pathol. 2003 Nov;34(11):1178-84.

PMID:
14652820
14.

Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.

Castro NP, Osório CA, Torres C, Bastos EP, Mourão-Neto M, Soares FA, Brentani HP, Carraro DM.

Breast Cancer Res. 2008;10(5):R87. doi: 10.1186/bcr2157. Epub 2008 Oct 17.

15.

Clonal relationship between closely approximated low-grade ductal and lobular lesions in the breast: a molecular study of 10 cases.

Wagner PL, Kitabayashi N, Chen YT, Shin SJ.

Am J Clin Pathol. 2009 Dec;132(6):871-6. doi: 10.1309/AJCP7AK1VWFNMCSW.

PMID:
19926578
16.

Molecular alterations in columnar cell lesions of the breast.

Dabbs DJ, Carter G, Fudge M, Peng Y, Swalsky P, Finkelstein S.

Mod Pathol. 2006 Mar;19(3):344-9.

17.
18.

Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity.

Reis-Filho JS, Simpson PT, Jones C, Steele D, Mackay A, Iravani M, Fenwick K, Valgeirsson H, Lambros M, Ashworth A, Palacios J, Schmitt F, Lakhani SR.

J Pathol. 2005 Sep;207(1):1-13.

PMID:
15957152
19.

Diagnostic and prognostic utility of molecular markers in synchronous bilateral breast carcinoma.

Saad RS, Denning KL, Finkelstein SD, Liu Y, Pereira TC, Lin X, Silverman JF.

Mod Pathol. 2008 Oct;21(10):1200-7. doi: 10.1038/modpathol.2008.35. Epub 2008 May 9.

20.

Loss of heterozygosity analysis shows monoclonal evolution with frequent genetic progression and divergence in esophageal carcinosarcoma.

Matsumoto T, Fujii H, Arakawa A, Yamasaki S, Sonoue H, Hattori K, Kajiyama Y, Hirose S, Tsurumaru M.

Hum Pathol. 2004 Mar;35(3):322-7.

PMID:
15017588

Supplemental Content

Support Center